Related Experiment Video
Updated: Aug 29, 2025
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy
Stephanny Miranda Alves de Souza1,2, Blanca Hernández-Ledesma3, Theo Luiz Ferraz de Souza1,2
1Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Abstract:
Cancer has become one of the main public health problems worldwide, demanding the development of new therapeutic agents that can help reduce mortality. Lunasin is a soybean peptide that has emerged as an attractive option because its preventive and therapeutic actions against cancer. In this review, we evaluated available research on lunasin's structure and mechanism of action, which should be useful for the development of lunasin-based therapeutic products. We described data on its primary, secondary, tertiary, and possible quaternary structure, susceptibility to post-translational modifications, and structural stability. These characteristics are important for understanding drug activity and characterizing lunasin products. We also provided an overview of research on lunasin pharmacokinetics and safety. Studies examining lunasin's mechanisms of action against cancer were reviewed, highlighting reported activities, and known molecular partners. Finally, we briefly discussed commercially available lunasin products and potential combination therapeutics.
Insights
Lunasin, a soybean peptide, shows promise for cancer prevention and therapy. This review details its structure, action mechanisms, pharmacokinetics, and safety, aiding the development of new cancer treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Cancer poses a significant global health challenge, necessitating novel therapeutic strategies.
- Lunasin, a peptide derived from soybeans, exhibits potential anticancer properties.
- Understanding lunasin's characteristics is crucial for developing effective cancer therapies.
Purpose of the Study:
- To review existing research on lunasin's structure and mechanism of action against cancer.
- To provide insights into lunasin's pharmacokinetic and safety profiles.
- To discuss the development of lunasin-based therapeutic products and combination therapies.
Main Methods:
- Comprehensive literature review of studies on lunasin's structure (primary, secondary, tertiary, quaternary).
- Analysis of lunasin's susceptibility to post-translational modifications and structural stability.
- Evaluation of research on lunasin's pharmacokinetics, safety, and anticancer mechanisms.
Main Results:
- Lunasin's structural characteristics, including modifications and stability, are detailed.
- Pharmacokinetic and safety data provide a basis for therapeutic development.
- Lunasin's anticancer activities and molecular interactions are elucidated.
Conclusions:
- Lunasin is a promising candidate for cancer prevention and therapy.
- Further research into its structure-activity relationship can optimize therapeutic applications.
- Lunasin holds potential for standalone or combination cancer treatment strategies.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
